Key takeaways
Joint pain is not a labeled side effect in the prescribing information for Zepbound (tirzepatide), but musculoskeletal complaints have been reported by people taking the medication.
Body aches on Zepbound may be due to dehydration, muscle soreness from physical activity, injection site reactions, or indirect effects of rapid weight loss.
Body aches on Zepbound can be managed by staying hydrated, prioritizing low-impact resistance training, eating anti-inflammatory foods, and rotating injection sites.
If body aches or muscle pain do not improve on their own, ask your provider for help determining the underlying cause or causes.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
Joint pain is not a labeled side effect in the prescribing information for Zepbound (tirzepatide), but musculoskeletal complaints have been reported by people taking the medication.
Body aches on Zepbound may be due to dehydration, muscle soreness from physical activity, injection site reactions, or indirect effects of rapid weight loss.
Body aches on Zepbound can be managed by staying hydrated, prioritizing low-impact resistance training, eating anti-inflammatory foods, and rotating injection sites.
If body aches or muscle pain do not improve on their own, ask your provider for help determining the underlying cause or causes.
If you’ve recently started Zepbound (tirzepatide) for weight loss, heightened awareness of how your body looks or feels is common. Noticing new pains or muscle soreness may prompt the question: does Zepbound cause body aches? The short answer: there is no evidence that it does.
Neither body aches nor muscle pain is listed as a side effect in Zepbound's prescribing information — but that does not mean body aches on Zepbound cannot or will not occur.
Below are possible reasons for Zepbound body aches and guidance on what to do if body aches occur while taking Zepbound.
Does Zepbound cause body aches?
Probably not. Body aches are not listed as a side effect of Zepbound. Clinical trials did not find that people taking tirzepatide (the active ingredient in Zepbound) had more body aches than those taking a placebo.
Still, complaints of joint pain and other body aches on Zepbound have been reported to the FDA's Adverse Events Reporting System (FAERS). From 2022 to 2025, FAERS received 473 reports of back pain, 393 reports of muscle spasm, and 513 reports of muscle pain on Zepbound.
That said, FAERS reports do not confirm causality. Experiencing body aches on Zepbound does not mean Zepbound caused them.
Why can Zepbound cause body aches?
There is no evidence that Zepbound directly causes body aches. However, if muscle pain or body aches occur on Zepbound, they could be due to an injection site reaction, indirect effects of rapid weight loss, or something else.
There are several potential reasons body aches may occur on Zepbound, including:
Dehydration. Vomiting and diarrhea are common tirzepatide side effects that can rapidly deplete the body of fluids, leading to dehydration, which can trigger muscle cramps and spasms — a possible explanation for Zepbound muscle pain or body aches.
DOMS from increased physical activity. Zepbound is meant to be used alongside an exercise plan (not exercising is a reason someone might not be losing weight on Zepbound). Delayed-onset muscle soreness (DOMS) is very common, especially when starting a new exercise routine or returning to physical activity after a long break.
Injection site reactions. Zepbound injection site reactions can cause pain, bruising, and swelling — a possible explanation for mild aches or muscle pain near a recent injection site.
Rapid weight loss. Zepbound can support significant weight loss and rapidly changing body composition. Without strength training to preserve muscle, achiness or soreness may result from muscle weakness — or, potentially, from the musculoskeletal system adjusting to support the body at a new weight.
Zepbound does not directly cause body aches, but some of its effects could potentially trigger a chain of events leading to aching or muscle pain.
How long do Zepbound body aches last?
It is unclear how long Zepbound muscle pain or body aches last, as there is no evidence that the medication itself causes these symptoms. Anecdotal reports suggest Zepbound muscle pain does resolve over time.
Pain duration may depend on the underlying cause. Some examples:
Muscle pain from dehydration or DOMS should improve within about 72 hours with adequate hydration and rest.
Injection site reactions usually resolve within three days.
Soreness from muscle loss or changes in body composition should improve gradually with a focus on rebuilding muscle and nourishing the body with protein-rich foods.
How to manage body aches on Zepbound
There are several ways to manage or relieve body aches while taking Zepbound, including staying hydrated and rotating injection sites.
Drink plenty of fluids
Dehydration can happen quickly — signs include thirst, general exhaustion, headaches, and muscle twitches. Keeping water nearby to sip throughout the day is a good practice.
Daily hydration needs vary depending on sex, body size, and activity level, but aiming for around 2–3 liters (about 8 to 12 cups) of liquid per day is generally recommended — more if fluid loss is elevated due to diarrhea or vomiting. Plain water is a good option, as are electrolyte-rich drinks like soda water, coconut water, no-sugar-added fruit juice, and broth.
Rotate your injection sites
If soreness is localized to a previous injection site, that is a sign to give the area a break. Even without soreness, Zepbound injection sites should be rotated weekly.
The recommended injection sites for Zepbound are the abdomen, thigh, or upper arm. Some research suggests that injecting into the abdomen may cause less pain than the thigh — but rotating sites consistently is the most important practice.
Keep moving
When feeling achy, it may be tempting to rest for the day. However, low-impact aerobic activity — such as swimming, walking, or biking — can support blood flow and reduce general achiness.
Resistance training is also key to maintaining muscle mass, which can help combat body aches caused by muscle underuse or weakness.
Optimize your nutrition
Zepbound works by slowing digestion and reducing appetite. As food intake decreases, the quality of what is consumed becomes even more important.
For body aches, focus on whole grains, fruits, vegetables, nuts, and healthy fats — all of which may help reduce painful inflammation.
Soreness from muscle weakness or loss may also be mitigated by prioritizing lean mass retention during weight loss. Research suggests that eating more protein can help protect lean muscle mass during weight loss. For personalized guidance, try the free protein calculator on Ro.
Consider an over-the-counter pain reliever
For soreness or achiness on Zepbound, an over-the-counter pain reliever such as acetaminophen (Tylenol) or an nonsteroidal anti-inflammatory drug (NSAID) such as ibuprofen may help.
As with any medication, consulting a healthcare provider before trying an over-the-counter treatment for the first time is advisable. It is important to confirm that pain relievers do not interact with other medications or conditions. For instance, NSAIDs should usually be avoided by people with kidney disease.
When to contact a healthcare provider
Most aches and pains on Zepbound are mild and manageable. It is a good idea to contact a healthcare provider if body aches worsen or do not improve after a few days.
Contact a healthcare provider promptly if any of the following symptoms occur:
Severe muscle pain
Unexplained muscle weakness
Muscle swelling, stiffness, or tenderness
Dark or brown urine
Reduced urine output
Fever
These may be signs of a condition that needs medical attention.
Bottom line
Zepbound does not directly cause body aches — but reports of muscle pain and body aches while taking Zepbound are not uncommon.
Here’s what to remember about Zepbound and body aches:
Body aches are not a direct effect of Zepbound itself. There is no evidence that Zepbound causes muscle pain.
Zepbound body aches can occur indirectly due to side effects or lifestyle changes. Vomiting or diarrhea can lead to dehydration, which may cause muscle cramps; a new exercise routine can cause soreness; and injection site irritation — or repeatedly injecting the same area — may contribute to localized muscle pain.
Rapid weight loss can also cause temporary aches and pains. Significant or rapid weight loss alters body composition, potentially leading to muscle loss and musculoskeletal aches or pains.
Body aches on Zepbound can be managed. Staying hydrated, focusing on low-impact exercise and strength training, and following a well-rounded, anti-inflammatory eating plan can all help.
Contact a healthcare provider when needed. If aches are severe, persistent, or worsening, a healthcare provider can help rule out other causes and discuss symptom management.
Frequently asked questions (FAQs)
Can Zepbound cause muscle pain?
Not directly. Localized muscle pain can occur if Zepbound is injected into a recent injection site or accidentally into a muscle instead of subcutaneous fat.
Can Zepbound cause muscle soreness?
Zepbound does not directly cause muscle soreness, but muscle soreness may occur when increasing exercise while on Zepbound or becoming dehydrated from Zepbound-related diarrhea or vomiting. Weakness or soreness may also occur if rapid weight loss from Zepbound leads to muscle loss.
How does Zepbound affect your muscles?
There’s no evidence that Zepbound directly affects your muscles. But rapid or significant weight loss from Zepbound can lead to muscle loss.
Should I stop Zepbound if I have body aches?
No. There is no data suggesting that body aches are a warning sign to stop Zepbound. Consult a healthcare provider if there are concerns about body aches on Zepbound or if the pain worsens or interferes with daily life.
Can Zepbound cause flu-like symptoms?
Zepbound can cause gastrointestinal symptoms, fatigue, and, in some cases, headaches — together, these can resemble flu-like symptoms. However, "flu-like symptoms" are not listed as a side effect in the prescribing information.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
References
Carbone, J. W. & Pasiakos, S. M. (2019). Dietary Protein and Muscle Mass: Translating Science to Application and Health Benefit. Nutrients, 11(5), 1136. doi: 10.3390/nu11051136. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6566799/
Cleary, M. A., Sitler, M. R., & Kendrick, Z. V. (2006). Dehydration and symptoms of delayed-onset muscle soreness in normothermic men. Journal of Athletic Training, 41(1), 36–45. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC1421497/
Drożdżal, S., Lechowicz, K., Szostak, B., et al. (2021). Kidney damage from nonsteroidal anti-inflammatory drugs-Myth or truth? Review of selected literature. Pharmacology Research & Perspectives, 9(4), e00817. doi: 10.1002/prp2.817. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8313037/
El-Amawy, H. S. (2026). Tirzepatide in dermatology: cutaneous adverse events, emerging therapeutic roles, and cosmetic implications - A comprehensive review. Anais Brasileiros de Dermatologia, 101(1), 501255. doi: 10.1016/j.abd.2025.501255. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12800350/
Fairbairn, L., Schuberth, A., Deacon, L., et al. (2023). A systematic review of subcutaneous versus intramuscular or intravenous routes of opioid administration on pain outcomes in cancer and post-surgical clinical populations - challenging current assumptions in palliative care practice. British Journal of Pain, 17(2), 152–165. doi: 10.1177/20494637221135835. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10088419/
Georgiev, T. & Kabakchieva, P. (2025). Weight Loss, but Not at Any Cost: Risks and Challenges in Patients with Osteoarthritis. Mediterranean Journal of Rheumatology, 36(1), 28–35. doi: 10.31138/mjr.121224.wlc. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12183455/
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. The New England Journal of Medicine, 387(3), 205–216. doi: 10.1056/NEJMoa2206038. Retrieved from https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
Kotowski, S. E. & Davis, K. G. (2010). Influence of weight loss on musculoskeletal pain: Potential short-term relevance. Work (Reading, Mass.), 36(3), 295–304. doi: 10.3233/WOR-2010-1031. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12421731/
Martins, C., Gower, B., & Hunter, G. R. (2022). Metabolic adaptation after combined resistance and aerobic exercise training in older women. Obesity (Silver Spring, Md.), 30(7), 1453–1461. doi: 10.1002/oby.23450. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9256770/
Meinders, A. J. & Meinders, A. E. (2010). Hoeveel water moeten we eigenlijk drinken? [How much water do we really need to drink?]. Nederlands Tijdschrift Voor Geneeskunde, 154, A1757. Retrieved from https://pubmed.ncbi.nlm.nih.gov/20356431/
National Research Council (US) Subcommittee on the Tenth Edition of the Recommended Dietary Allowances. (1989). Water and Electrolytes. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK234935/
Nunes, E. A., Colenso-Semple, L., McKellar, S. R., et al. (2022). Systematic review and meta-analysis of protein intake to support muscle mass and function in healthy adults. Journal of Cachexia, Sarcopenia and Muscle, 13(2), 795–810. doi: 10.1002/jcsm.12922. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8978023
Reddit. (2023). Sore muscles & joint pains. Retrieved from https://www.reddit.com/r/Mounjaro/comments/181zbiw/sore_muscles_joint_pains/
Rout, P., Chippa, V. & Adigun, R. (2025). Rhabdomyolysis. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK448168/
Sattar, N., Neeland, I. J., Dahlqvist Leinhard, O., et al. (2025). Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial. The Lancet. Diabetes, 13(6), 482-493. doi: 10.1016/S2213-8587(25)00027-0. Retrieved from https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00027-0/fulltext
Søgaard, K. & Sjøgaard, G. (2017). Physical Activity as Cause and Cure of Muscular Pain: Evidence of Underlying Mechanisms. Exercise and Sport Sciences Reviews, 45(3), 136–145. doi: 10.1249/JES.0000000000000112. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC5473374/
Sonavane, K., Shirsat, P., Agrawal, G., et al. (2025). Rhabdomyolysis associated with the use of tirzepatide. European Journal of Case Reports in Internal Medicine, 12(5), 005392. doi: 10.12890/2025_005392. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12061213
Taylor, K. & Tripathi, A.K. (2025) Adult Dehydration. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK555956
Usach, I., Martinez, R., Festini, T., & Peris, J. E. (2019). Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site. Advances in Therapy, 36(11), 2986–2996. doi: 10.1007/s12325-019-01101-6. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6822791
U.S. Food and Drug Administration (FDA-a). (2026). FDA Adverse Event Monitoring System (FAERS) Public Dashboard for Drugs and Biologics. Retrieved on May 20, 2026 from https://fis.fda.gov/sense/app/95239e26-e0be-42d9-a960-9a5f7f1c25ee/sheet/45beeb74-30ab-46be-8267-5756582633b4/state/analysis
U.S. Food and Drug Administration (FDA-b). (2026). Highlights of prescribing information: Zepbound (tirzepatide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s042lbl.pdf
Wiecha, S., Posadzki, P., Prill, R., & Płaszewski, M. (2024). Physical Therapies for Delayed Onset Muscle Soreness: A Protocol for an Umbrella and Mapping Systematic Review with Meta-Meta-Analysis. Journal of Clinical Medicine, 13(7), 2006. doi: 10.3390/jcm13072006. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11012564/
Yu, X., Pu, H., & Voss, M. (2024). Overview of anti-inflammatory diets and their promising effects on non-communicable diseases. The British Journal of Nutrition, 132(7), 898–918. doi: 10.1017/S0007114524001405. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11576095/














